复方苦参注射液抗肿瘤、镇痛活性评价及机制研究Anti-tumor and analgesic activity evaluation and mechanism of Compound Kushen Injection
范琦琦;折改梅;魏静;李芝奇;陈美琳;董英;于啊香;李建伟;秦文杰;王伟;林瑞超;赵崇军;游蓉丽;
FAN Qi-qi;SHE Gai-mei;WEI Jing;LI Zhi-qi;CHEN Mei-lin;DONG Ying;YU A-xiang;LI Jian-wei;QIN Wen-jie;WANG Wei;LIN Rui-chao;ZHAO Chong-jun;YOU Rong-li;Beijing Key Laboratory for Quality Evaluation of Chinese Materia Medica, School of Chinese Materia Medica, Beijing University of Chinese Medicine;Beijing Zhendong Guangming Pharmaceutical Research Institute Co., Ltd.;
摘要(Abstract):
该研究基于体内斑马鱼模型评价复方苦参注射液(compound kushen injection, CKI)抗肿瘤及镇痛活性,并探究其抗肿瘤的作用机制。通过斑马鱼卵黄囊显微注射LPC H12肝癌细胞建立斑马鱼肿瘤异种移植模型,实验过程中设置复方苦参注射液高(H-CKI)、中(M-CKI)、低(L-CKI)剂量组和模型组,给药72 h后以肿瘤面积增长倍数、积分吸光度(integrated absorbance, IA)增长倍数为指标评价CKI对肿瘤的抑制作用;分别以冰乙酸(acetic acid, AA)和佛波酯(phorbol myristate acetate, PMA)建立斑马鱼外周疼痛和中枢疼痛模型,利用行为轨迹分析系统监测斑马鱼行为运动轨迹,以运动次数、运动时间、运动距离、运动速度等运动状态为指标评价CKI的镇痛活性;最后,通过实时定量聚合酶链反应(real-time quantitative polymerasechain reaction, RT-qPCR)检测B淋巴细胞瘤-2基因(B lymphocyte tumor-2, Bcl-2)与磷脂酰肌醇-3-激酶(phosphatidylinositol-3-kinase, PI3K)/蛋白激酶B(protein kinase B,Akt或PKB)通路相关基因的表达,验证抗肿瘤作用机制。与模型组相比,M-CKI组和H-CKI组肿瘤面积及积分吸光度的增长倍数显著降低,对外周疼痛和中枢疼痛具有明显的缓解作用,机制研究发现CKI能够上调半胱氨酸天冬氨酸蛋白酶3(caspase-3, Casp3)、半胱氨酸天冬氨酸蛋白酶9(caspase-9, Casp9)表达,下调PI3K、Akt表达,且Bcl-2、缺氧诱导因子-1α(hypoxia-inducible factor 1α, HIF-1α)、血管内皮生长因子(vascular endothelial growth factor, VEGF)表达水平显著降低。综上,CKI具有显著的抑制肿瘤生长及镇痛的功效,其机制与PI3K/Akt信号通路有关,该通路介导细胞凋亡,抑制肿瘤生长,缓解肿瘤疼痛。
This study aims to evaluate the anti-tumor and analgesic activities of Compound Kushen Injection(CKI) based on zebrafish model in vivo and investigate the anti-tumor mechanism. To be specific, zebrafish tumor xenotransplantation model was established by microinjection of murine LPC H12 cells into yolk sac. Then the high-dose CKI(H-CKI), medium-dose CKI(M-CKI), low-dose CKI(L-CKI) groups, and the model group were set. The anti-tumor activity of CKI was evaluated with the tumor area growth fold and integral absorbance(IA) growth fold 72 h after administration. The peripheral pain and central pain in zebrafish were respectively induced with acetic acid(AA) and phorbol myristate acetate(PMA). Zebralab ViewPoint system was employed to monitor behavioral trajectory of zebrafish, and movement times, movement time, movement distance, and movement velocity were used to evaluate the analgesic activity of CKI. Finally, real-time fluorescence quantitative polymerase chain reaction(RT-qPCR) was performed to detect the expression levels of apoptosis-related B lymphocyte tumor-2(Bcl-2) and phosphatidylinositol-3-kinase(PI3 K)/protein kinase B(Akt or PKB) pathway-related genes, for the verification of the anti-tumor mechanism. Compared with the model group, M-CKI and H-CKI significantly reduced the growth folds of tumor area and IA, relief the peripheral pain and central pain. The mechanism was that CKI can up-regulate the expression of cysteine aspartic acid specific protease-3(caspase-3, Casp3) and caspase-9(Casp9), down-regulate the expression of phosphoinositide 3-kinase(PI3 K) and Akt, and significantly reduce the expression of Bcl-2, hypoxia-inducible factor-1α(HIF-1α), and vascular endothelial growth factor(VEGF). In conclusion, CKI has significant inhibitory effect on tumor growth and pain, which is related to the PI3 K/Akt signaling pathway. The pathway mediates cell apoptosis, suppresses tumor growth, and alleviates tumor pain.
关键词(KeyWords):
复方苦参注射液;活性;机制;抗肿瘤;镇痛;RT-qPCR
Compound Kushen Injection(CKI);activity;mechanism;anti-tumor;analgesic;RT-qPCR
基金项目(Foundation): 国家“重大新药创制”科技重大专项(2018ZX09735005);; 北京中医药大学新教师启动基金项目(2020-JYB-XJSJJ-009);北京中医药大学重点攻关项目(2020-JYB-ZDGG-035);; 国家中药标准化项目(ZYBZH-C-JIN-43);; 山西省重点研发计划重点项目(201603D3113011)
作者(Authors):
范琦琦;折改梅;魏静;李芝奇;陈美琳;董英;于啊香;李建伟;秦文杰;王伟;林瑞超;赵崇军;游蓉丽;
FAN Qi-qi;SHE Gai-mei;WEI Jing;LI Zhi-qi;CHEN Mei-lin;DONG Ying;YU A-xiang;LI Jian-wei;QIN Wen-jie;WANG Wei;LIN Rui-chao;ZHAO Chong-jun;YOU Rong-li;Beijing Key Laboratory for Quality Evaluation of Chinese Materia Medica, School of Chinese Materia Medica, Beijing University of Chinese Medicine;Beijing Zhendong Guangming Pharmaceutical Research Institute Co., Ltd.;
DOI: 10.19540/j.cnki.cjcmm.20211129.701
参考文献(References):
- [1] 胡文兵,高清平.复方苦参注射液对肝癌HepG2细胞放疗的增敏作用观察[J].山东医药,2010,50(45):32.
- [2] 雷娜,张博,裴迎霞,等.复方苦参注射液诱导人肝癌SMMC-7221细胞凋亡的研究[J].国际中医中药杂志,2012,34(3):217.
- [3] 海丽娜,王佳敏,赵婧,等.血清化学与网络药理学关联研究复方苦参注射液对肝癌小鼠的作用机理[J].中药药理与临床,2020,36(4):167.
- [4] 朱艳志,孔宪炳,颜朗.SD大鼠肝细胞癌模型Hedgehog信号通路与复方苦参干预后的效应[J].中国组织工程研究与临床康复,2011,15(2):257.
- [5] 宋亚刚,白明,崔琳琳,等.基于数据发掘探寻肝癌中医临床用药的宏观规律[J].中国实验方剂学杂志,2021,27(13):146.
- [6] CHEN W,ZHENG R,BAADE P D,et al.Cancer statistics in China,2015[J].CA Cancer J Clin,2016,66(2):115.
- [7] WHO.Global battle against cancer won′t be won with treatment alone-effective prevention measures urgently needed to prevent cancer crisis[J].Cent Eur J Public Health,2014,22(1):23.
- [8] 李果,朱柱,戴小明,等.肝癌动物模型建立的研究进展[J].医学综述,2018,24(2):285.
- [9] 王培培,王永辉,王丽森,等.华蟾素辅助顺铂化疗对H22肝癌小鼠的抑瘤作用及其相关机制研究[J].中国中药杂志,2020,45(16):3945.
- [10] 赵亚楠,杨爱琳,庞道然,等.龙血竭中双黄酮化合物HIS-4对人肝癌HepG2和SK-HEP-1细胞的抗肿瘤作用研究[J].中国中药杂志,2019,44(7):1442.
- [11] 刘玲,赵建龙,王建刚.齐墩果酸诱导人肝癌Bel-7402细胞G2/M期阻滞及凋亡的机制研究[J].中国中药杂志,2015,40(24):4897.
- [12] GOESSLING W,NORTH T E,ZON L I,et al.New waves of discovery:modeling cancer in zebrafish[J].J Clin Oncol,2007,25:2473.
- [13] VEINOTTE C J,DELLAIRE G,BERMAN J N,et al.Hooking the big one:the potential of zebrafish xenotransplantation to reform cancer drug screening in the genomic era[J].Dis Model Mech,2014,7:745.
- [14] 李小梅,袁文茜,曹伯旭,等.慢性癌症相关性疼痛[J].中国疼痛医学杂志,2021,27(3):161.
- [15] MALAFOGLIA V,COLASANTI M,RAFFAELI W,et al.Extreme thermal noxious stimuli induce pain responses in zebrafish larva[J].J Cell Physiol,2014,229:300.
- [16] ROQUES J A C,ABBINK W,CHEREAU G,et al.Physiological and behavioral responses to an electrical stimulus in Mozambique tilapia (Oreochromis mossambicus)[J].Fish Physiol Biochem,2012,38(4):1019.
- [17] JESSICA J M,LOIS J O,CATHERINE R M,et al.The efficacy of three types of analgesic drugs in reducing pain in the rainbow trout,Oncorhynchus mykiss[J].Appl Anim Behav Sci,2011,133(3):265.
- [18] ANA D C,SéRGIO R C,MARTIN S,et al.A novel behavioral fish model of nociception for testing analgesics[J].Pharmaceuticals,2011,4(4):83.
- [19] DUNLOP R,LAMING P.Mechanoreceptive and nociceptive responses in the central nervous system of goldfish (Carassius auratus) and trout (Oncorhynchus mykiss)[J].J Pain,2005,6(9):561.
- [20] JANICKE N,YOR E H,BIRGIT R,et al.Somatosensory evoked potentials in the telencephalon of Atlantic salmon (Salmo salar ) following galvanic stimulation of the tail[J].J Comp Physiol A,2007,193:1235.
- [21] CARON S J C,PROBER D,CHOY M,et al.In vivo birthdating by BAPTISM reveals that trigeminal sensory neuron diversity depends on early neurogenesis[J].Development,2008,135(19):3259.
- [22] GAU P,POON J,UFRET-VINCENTY C,et al.The zebrafish ortholog of TRPV1 is required for heat-induced locomotion[J].J Neurosci,2013,33(12):5249.
- [23] VALERIO D A,GEORGETTI S R,MAGRO D A,et al.Quercetin reduces inflammatory pain:inhibition of oxidative stress and cytokine production[J].J Nat Prod,2009,72(11):1975.
- [24] RONALDO A R,MARIANA L V,SARA M T,et al.Involvement of resident macrophages and mast cells in the writhing nociceptive response induced by zymosan and acetic acid in mice[J].Eur J Pharmacol,2000,387(1):111.
- [25] TAYLOR J C,DEWBERRY L S,TOTSCH S K,et al.A novel zebrafish-based model of nociception[J].Physiol Behav,2017,174:83.
- [26] PETER J S,NABILA B.Antinociceptive effects of buprenorphine in zebrafish larvae:an alternative for rodent models to study pain and nociception?[J].Appl Anim Behav Sci,2014,152:92.
- [27] JAVIER L L,OUSSAY A J,WALEED A N,et al.Reduction in activity by noxious chemical stimulation is ameliorated by immersion in analgesic drugs in zebrafish[J].J Exp Biol,2017,220(8):1451.
- [28] 杜婷婷,王海苹,徐懿乔,等.斑马鱼模型评价如意珍宝丸抗炎镇痛作用研究[J].广东药科大学学报,2017,33(4):498.
- [29] 刘琳,罗晓光,王新红,等.大鼠黑质反复佛波酯(PMA)注射诱导小胶质细胞老化及其与帕金森病关系的探讨[C].重庆:中华医学峰会暨中华医学会神经病学分会第八届全国中青年神经病学学术会,2015.
- [30] 李旭东.银杏叶提取物对大鼠肾脏收缩再灌注损伤的保护作用及机制的实验研究[D].青岛:青岛大学,2008.
- [31] 陈稀烦,魏晓炎,侯乐萍.华蟾素对肺癌大鼠PI3K/AKT信号通路的抑制作用[J].中国现代应用药学,2020,37(4):425.
- [32] NAPOLEONE F.Vascular endothelial growth factor:basic science and clinical progress[J].Endocr Rev,2004,25(4):581.
- [33] 赵妙惠,周佳妮,漆勇.桑黄多糖调控PI3K/AKT/mTOR通路抑制肝癌腹水荷瘤小鼠及对化疗的减毒增效作用[J].中国临床药理学与治疗学,2020,25(4):401.
- [34] DI J H,GAO K Y,QU D B,et al.Rap2B promotes angiogenesis via PI3K/AKT/VEGF signaling pathway in human renal cell carcinoma[J].Tumour Biol,2017,39(7):1010428317701653.
- [35] KIZAKA-KONDON S,KUCHIMARU T,KADONOSONO T.Pathophysiological response to hypoxia from the molecular mechanisms of malady to drug discovery:hypoxia-inducible factor-1 (HIF-1)-active cells as a target for cancer therapy[J].J Pharmacol Sci,2011,115:440.
- [36] SHOHREH A G,MOHAMMAD H M.Identification and expression analysis of zebrafish testis-specific gene 10 (TSGA10)[J].Int J Dev Biol,2019,63:623.
- 范琦琦
- 折改梅
- 魏静
- 李芝奇
- 陈美琳
- 董英
- 于啊香
- 李建伟
- 秦文杰
- 王伟
- 林瑞超
- 赵崇军
- 游蓉丽
FAN Qi-qi- SHE Gai-mei
- WEI Jing
- LI Zhi-qi
- CHEN Mei-lin
- DONG Ying
- YU A-xiang
- LI Jian-wei
- QIN Wen-jie
- WANG Wei
- LIN Rui-chao
- ZHAO Chong-jun
- YOU Rong-li
- Beijing Key Laboratory for Quality Evaluation of Chinese Materia Medica
- School of Chinese Materia Medica
- Beijing University of Chinese Medicine
- Beijing Zhendong Guangming Pharmaceutical Research Institute Co.
- Ltd.
- 范琦琦
- 折改梅
- 魏静
- 李芝奇
- 陈美琳
- 董英
- 于啊香
- 李建伟
- 秦文杰
- 王伟
- 林瑞超
- 赵崇军
- 游蓉丽
FAN Qi-qi- SHE Gai-mei
- WEI Jing
- LI Zhi-qi
- CHEN Mei-lin
- DONG Ying
- YU A-xiang
- LI Jian-wei
- QIN Wen-jie
- WANG Wei
- LIN Rui-chao
- ZHAO Chong-jun
- YOU Rong-li
- Beijing Key Laboratory for Quality Evaluation of Chinese Materia Medica
- School of Chinese Materia Medica
- Beijing University of Chinese Medicine
- Beijing Zhendong Guangming Pharmaceutical Research Institute Co.
- Ltd.